⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL907639 | 1.00 | — | — | |
| SCHEMBL9188538 | 1.00 | — | — | |
| SCHEMBL8389 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL5609160 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL232631 | 0.97 | — | — | |
| SCHEMBL25302485 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL1577130 | 0.97 | — | — | |
| SCHEMBL29034425 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL3086623 | 0.97 | — | — | |
| SCHEMBL25255331 | 0.97 | TSHR (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7799952-B2 | Stereoselective method for the production of (R)-Dimepranol | RATIOPHARM GMBH (DE) | 2010-09-21 | — | — | US | claimed |
| US-20090149677-A1 | Stereoselective Method for the Production of (R)-Dimepranol | RATIOPHARM GMBH (DE) | 2009-06-11 | — | — | US | claimed |
| US-12630566-B2 | KRas G12D inhibitors | Mirati Therapeutics, Inc. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260124147-A1 | THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING MOVEMENT DISORDERS | Vima Therapeutics, Inc. (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4142732-B1 | METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS | GLOBAL BLOOD THERAPEUTICS INC (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260001846-A1 | SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS | SERVIER LAB (FR) | 2026-01-01 | — | — | US | disclosed |
| US-20250339418-A1 | THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING MOVEMENT DISORDERS | Vima Therapeutics, Inc. (US) | 2025-11-06 | — | — | US | disclosed |
| US-20250268883-A1 | THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING MOVEMENT DISORDERS | Vima Therapeutics, Inc. (US) | 2025-08-28 | — | — | US | disclosed |
| US-12290513-B2 | Therapeutic methods and compositions for treating movement disorders | Vima Therapeutics, Inc. (US) | 2025-05-06 | — | — | US | disclosed |
| CN-119816491-A | New spirocyclohexane derivatives, pharmaceutical compositions containing them and their use as anti-apoptotic inhibitors | 法国施维雅药厂 | 2025-04-11 | — | — | CN | disclosed |
| US-20250109122-A1 | CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS | GLOBAL BLOOD THERAPEUTICS INC (US) | 2025-04-03 | — | — | US | disclosed |
| EP-1737868-A1 | STEREOSELECTIVE METHOD FOR THE PRODUCTION OF CLOPIDOGREL | ratiopharm GmbH (DE) | 2007-01-03 | — | — | EP | disclosed |
| WO-2005113559-A1 | STEREOSELECTIVE METHOD FOR THE PRODUCTION OF CLOPIDOGREL | RATIOPHARM GMBH (DE) | 2005-12-01 | — | — | WO | disclosed |
| EP-1589019-A1 | Stereoselective process for the preparation of Clopidogrel | Ratiopharm GmbH (DE) | 2005-10-26 | — | — | EP | disclosed |
| US-20030045727-A1 | Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2003-03-06 | — | — | US | disclosed |
| EP-1254885-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE SECONDARY ALCOHOLS HAVING NITROGENOUS OR OXYGENIC FUNCTIONAL GROUPS | Asahi Kasei Kabushiki Kaisha (JP) | 2002-11-06 | — | — | EP | disclosed |
| US-6143933-A | Process for the preparation of optically active methadones in high enantiomeric purity | SALFORD ULTRAFINE CHEMICALS & RESEARCH LTD. (GB) | 2000-11-07 | — | — | US | disclosed |
| EP-0914464-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE METHADONES IN HIGH ENANTIOMERIC PURITY | SALFORD ULTRAFINE CHEMICALS AND RESEARCH LIMITED (GB) | 1999-05-12 | — | — | EP | disclosed |
| WO-1997045551-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE METHADONES IN HIGH ENANTIOMERIC PURITY | SALFORD ULTRAFINE CHEMICALS & RESEARCH LIMITED (GB) | 1997-12-04 | — | — | WO | disclosed |
| EP-0641564-A1 | OPTICALLY ACTIVE CONDENSED PYRAZOLE COMPOUND FOR USE IN TREATING THROMBOCYTOPENIA AND ERYTHROPENIA | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1995-03-08 | — | — | EP | disclosed |